Radioiodine News and Research

RSS
Iodine-131 (131I), also called radioiodine (though many other radioactive isotopes of this element are known), is an important radioisotope of iodine. It has a radioactive decay half life of about eight days. Its uses are mostly medical and pharmaceutical.
Researchers develop technique to track proteins on the surfaces of endoplasmic reticulum in cells

Researchers develop technique to track proteins on the surfaces of endoplasmic reticulum in cells

Low risk thyroid cancer patients can be treated with smaller amount of radiation, suggests study

Low risk thyroid cancer patients can be treated with smaller amount of radiation, suggests study

International panel reclassifies a type of thyroid tumor to reduce cancer overdiagnosis

International panel reclassifies a type of thyroid tumor to reduce cancer overdiagnosis

New ATA guidelines for managing adult patients with thyroid nodules and DTC published in Thyroid journal

New ATA guidelines for managing adult patients with thyroid nodules and DTC published in Thyroid journal

Intensive therapy needed in paediatric triiodothyronine-predominant Graves' disease

Intensive therapy needed in paediatric triiodothyronine-predominant Graves' disease

Lenvatinib therapy improves survival in patients with advanced radioiodine-refractory thyroid cancer

Lenvatinib therapy improves survival in patients with advanced radioiodine-refractory thyroid cancer

Novel therapeutic approaches to improve thyroid cancer outcomes

Novel therapeutic approaches to improve thyroid cancer outcomes

Scientists identify new biomarker for diagnosing cause of thyroid cancer

Scientists identify new biomarker for diagnosing cause of thyroid cancer

Eisai announces results from Phase III SELECT trial of lenvatinib evaluating PFS in patients with RR-DTC

Eisai announces results from Phase III SELECT trial of lenvatinib evaluating PFS in patients with RR-DTC

Scientists discover potential cure for triple negative breast cancer

Scientists discover potential cure for triple negative breast cancer

Overutilization of radioactive iodine to treat PTC leads to worse access to health care

Overutilization of radioactive iodine to treat PTC leads to worse access to health care

Ohio State University researchers awarded NCI grant to further study thyroid cancer

Ohio State University researchers awarded NCI grant to further study thyroid cancer

FDA grants Priority Review designation to sNDA for Nexavar tablets

FDA grants Priority Review designation to sNDA for Nexavar tablets

New guidance on radioiodine therapy use after radiographic studies

New guidance on radioiodine therapy use after radiographic studies

First combination treatment of microwave ablation, radiotherapy performed on 52-year-old patient

First combination treatment of microwave ablation, radiotherapy performed on 52-year-old patient

Genzyme receives EC approval for Thyrogen product label expansion

Genzyme receives EC approval for Thyrogen product label expansion

New York State Department of Health issues license to Veracyte's Afirma Gene Expression Classifier

New York State Department of Health issues license to Veracyte's Afirma Gene Expression Classifier

Vandetanib shows efficacy in thyroid cancer

Vandetanib shows efficacy in thyroid cancer

First detailed analysis of Fukushima Daiichi nuclear disaster's global health effects

First detailed analysis of Fukushima Daiichi nuclear disaster's global health effects

SPECT/CT can change clinical management of thyroid cancer

SPECT/CT can change clinical management of thyroid cancer